Showing results (91-100 of 4,133) with videos related to

Sort By:
Pageof 414
Der Anaesthesist|June 1, 1987
[Intracranial pressure in patients with craniocerebral trauma after administration of propofol and thiopental]H J Hartung
Wiener Medizinische Wochenschrift (1946)|January 1, 1996
[Pathogenesis of multiple sclerosis: status of research]H P Hartung
FEBS Letters|August 22, 1983
Acetyl glyceryl ether phosphorylcholine (platelet-activating factor) mediates heightened metabolic activity in macrophages. Studies on PGE, TXB2 and O2- production, spreading, and the influence of calmodulin-inhibitor W-7H P Hartung
Therapeutic Advances in Neurological Disorders|March 1, 2021
Health economics of disease-modifying therapy for multiple sclerosis in the United StatesDaniel M Hartung
Der Anaesthesist|October 1, 1988
[Clinical experiences with alfentanil for balanced anesthesia in upper abdominal surgery]H J Hartung
Medizinische Klinik (Munich, Germany : 1983)|October 18, 2001
[Current status of interferon beta-1b in multiple sclerosis therapy]H P Hartung
Journal of Neurology|September 20, 2008
Advances in the understanding of the mechanism of action of IVIgHans-Peter Hartung
Der Nervenarzt|September 26, 2009
[Atacicept: a new B lymphocyte-targeted therapy for multiple sclerosis]H-P Hartung
Der Anaesthesist|February 1, 1987
[Modification of intracranial pressure by propofol (Disoprivan). Initial results]H J Hartung
Neurology(R) Neuroimmunology & Neuroinflammation|June 7, 2020
Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MSHans-Peter Hartung,
Pageof 414